Abbott Laboratories (ABT) Asset Writedowns and Impairment (2016)
Abbott Laboratories (ABT) reported Asset Writedowns and Impairment of $947.0 million for Q3 2016.
Abbott Laboratories (ABT) Asset Writedowns and Impairment (2016) Analysis & Trends
Abbott Laboratories (ABT) has 1 years of Asset Writedowns and Impairment data on file, last reported at $947.0 million in Q3 2016.
- For the quarter ending Q3 2016, Asset Writedowns and Impairment changed N/A year-over-year to $947.0 million; the trailing twelve-month figure through Sep 2016 stood at $947.0 million (changed N/A YoY), and the FY2016 full-year result was $947.0 million, changed N/A from the prior year.
- Asset Writedowns and Impairment was little changed at $947.0 million in Q3 2016.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $947.0 million in Q3 2016 to a low of $947.0 million in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 947.00 Mn |
| Sep 30, 2016 | 947.00 Mn |